Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
for Malignant Solid Neoplasm
Sites in Portland, Oregon City +586 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT04871542·Recruiting·Listed May 2021
Oncology Clinical Trials in Portland, OR
As of August 2026, 235 paid clinical trials are recruiting for Oncology in Portland, Oregon. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
236 clinical trials for Oncology
·Clear filters· Email me when a new oncology trial opens in Portland, OR.
Precision-Based Genomics in Prostate Cancer
for Prostate Cancer
Sites in Portland +10 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Male·Age: 18 - 120
Code: NCT04706663·Recruiting·Listed Jan 2021
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for Rectal Cancer
Sites in Portland, Gresham +101 more locations
Sponsor: Canadian Cancer Trials Group
Sex: All·Age: 18+
Code: NCT06205485·Phase 3·Recruiting·Listed Jan 2024
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
for Rectal Adenocarcinoma
Sites in Portland +2 more locations
Sponsor: University of Colorado, Denver
Sex: All·Age: 18 - 100
Code: NCT07292298·Phase 2·Recruiting·Listed Dec 2025
Connect for Cancer Prevention Study (Connect)
for Cancer
Sites in Portland +8 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 30 - 70·Accepts healthy volunteers
Code: NCT04609072·Recruiting·Listed Oct 2020
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for Locoregional Recurrence
Drug: Ribociclib
Sites in Portland +18 more locations
Sponsor: Oana Danciu
Sex: All·Age: 18+
Code: NCT05467891·Phase 2·Recruiting·Listed Jul 2022
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
for Cancer
Sites in Portland +1 more location
Sponsor: State University of New York at Buffalo
Sex: All·Age: 18+
Code: NCT06206941·Recruiting·Listed Jan 2024
CREATE: Art for Children With Cancer
for Hematopoietic and Lymphatic System Neoplasm
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 8 - 13
Code: NCT06342453·Recruiting·Listed Apr 2024
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
for Acute Myeloid Leukemia
Drug: Venetoclax
Sites in Portland +3 more locations
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 18+
Code: NCT03471260·Phase 1, Phase 2·Recruiting·Listed Mar 2018
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for Lung Non-Small Cell Carcinoma
Sites in Portland, Oregon City +241 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT06116682·Phase 2·Recruiting·Listed Nov 2023
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
for Advanced Solid Tumors
1 location in Portland
Sponsor: Providence Health & Services
Sex: All·Age: 18+
Code: NCT06719362·Phase 1·Recruiting·Listed Dec 2024
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
for Metastatic Prostate Cancer
Sites in Portland +16 more locations
Sponsor: VA Office of Research and Development
Sex: Male·Age: 18+
Code: NCT05011383·Phase 2·Recruiting·Listed Aug 2021
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
for Acute Biphenotypic Leukemia
Sites in Portland +7 more locations
Sponsor: Fred Hutchinson Cancer Center
Sex: All·Age: 6 Months - 26·Accepts healthy volunteers
Code: NCT03779854·Phase 2·Recruiting·Listed Dec 2018
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
for Malignant Solid Tumors
Sites in Portland +2 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 4 Weeks+·Accepts healthy volunteers
Code: NCT03739827·Recruiting·Listed Nov 2018
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
for High-risk Smoldering Multiple Myeloma
Sites in Portland +2 more locations
Sponsor: Irene Ghobrial, MD
Sex: All·Age: 18+
Code: NCT05469893·Phase 2·Recruiting·Listed Jul 2022
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
for Advanced Malignant Solid Neoplasm
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+
Code: NCT05705492·Phase 2·Recruiting·Listed Jan 2023
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
for Acute Myeloid Leukemia
Sites in Portland +1 more location
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+
Code: NCT04659616·Phase 1·Recruiting·Listed Dec 2020
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for Breast Carcinoma
Sites in Portland, Baker City +462 more locations
Sponsor: Wake Forest University Health Sciences
Sex: All·Age: 18+
Code: NCT06418204·Recruiting·Listed May 2024
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
for Advanced Malignant Solid Neoplasm
Drug: Retifanlimab
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+
Code: NCT06320405·Phase 1, Phase 2·Recruiting·Listed Mar 2024
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
for Diffuse Large B-Cell Lymphoma
Drug: Mosunetuzumab
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18 - 75
Code: NCT06249191·Phase 1, Phase 2·Recruiting·Listed Feb 2024
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
for Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Drug: Ruxolitinib
1 location in Portland
Sponsor: Jennifer Saultz
Sex: All·Age: 18+
Code: NCT03874052·Phase 1·Recruiting·Listed Mar 2019
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
for Prostate Cancer
Sites in Portland +34 more locations
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male·Age: 21+
Code: NCT03151629·Recruiting·Listed May 2017
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for Brain Metastases
Sites in Portland +37 more locations
Sponsor: Canadian Cancer Trials Group
Sex: All·Age: 18+
Code: NCT03550391·Phase 3·Recruiting·Listed Jun 2018
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
for Acute Myeloid Leukemia
Drug: Iadademstat
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+
Code: NCT06357182·Phase 1·Recruiting·Listed Apr 2024
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for Breast Neoplasms
Sites in Portland +32 more locations
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All·Age: 18+
Code: NCT01042379·Phase 2·Recruiting·Listed Jan 2010
IVIG for Infection Prevention After CAR-T-Cell Therapy
for Hematologic Malignancies
Sites in Portland +6 more locations
Sponsor: Fred Hutchinson Cancer Center
Sex: All·Age: 18+
Code: NCT05952804·Phase 2·Recruiting·Listed Jul 2023
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
for Hematopoietic and Lymphatic System Neoplasm
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+
Code: NCT06895473·Phase 2·Recruiting·Listed Mar 2025
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
for Prostate Cancer
Sites in Portland +11 more locations
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male·Age: 18+
Code: NCT06457919·Phase 1, Phase 2·Recruiting·Listed Jun 2024
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
for Lung Carcinoma
Sites in Portland & Hillsboro
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18 - 99
Code: NCT05407168·Recruiting·Listed Jun 2022
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
for Multiple Myeloma
Sites in Portland +9 more locations
Sponsor: University of Alabama at Birmingham
Sex: All·Age: 18+
Code: NCT05231629·Phase 2·Recruiting·Listed Feb 2022
Identifying and Caring for Individuals With Inherited Cancer Syndrome
for BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
2 locations in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT04494945·Recruiting·Listed Jul 2020
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
for Neuroblastoma
Sites in Portland +19 more locations
Sponsor: Giselle Sholler
Sex: All·Age: Up to 22
Code: NCT02559778·Phase 2·Recruiting·Listed Sep 2015
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
for Anatomic Stage IV Breast Cancer AJCC v8
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18 - 100
Code: NCT04529044·Phase 2·Recruiting·Listed Aug 2020
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
for Prostate Carcinoma
Sites in Portland +6 more locations
Sponsor: University of Washington
Sex: Male·Age: 40+·Accepts healthy volunteers
Code: NCT04472338·Recruiting·Listed Jul 2020
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
for Neuroblastoma
Sites in Portland +11 more locations
Sponsor: Giselle Sholler
Sex: All·Age: 1 - 21
Code: NCT06540963·Phase 2·Recruiting·Listed Aug 2024
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
for Prostate Carcinoma
1 location in Portland
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+
Code: NCT06011499·Recruiting·Listed Aug 2023
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for Diffuse Large B-Cell Lymphoma
Sites in Portland, Oregon City +81 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT05633615·Phase 2·Recruiting·Listed Dec 2022
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for Prostate Adenocarcinoma
Sites in Portland, Oregon City +130 more locations
Sponsor: SWOG Cancer Research Network
Sex: Male·Age: 18+
Code: NCT05806515·Phase 2·Recruiting·Listed Apr 2023
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for Hematopoietic and Lymphatic System Neoplasm
Sites in Portland +75 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: 15 - 20
Code: NCT06410209·Phase 2·Recruiting·Listed May 2024
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
for Acute Monocytic Leukemia
Drug: Venetoclax
Sites in Portland +1 more location
Sponsor: OHSU Knight Cancer Institute
Sex: All·Age: 18+
Code: NCT06504459·Phase 2·Recruiting·Listed Jul 2024
Conditions in Oncology (Portland, OR)
Solid tumor· 43Non-small cell lung cancer (NSCLC)· 34Breast cancer· 22Acute myeloid leukemia (AML)· 20Prostate cancer· 19Cancer (any)· 18Endometrial cancer· 17Colorectal cancer· 16Ovarian cancer· 16Melanoma· 14Hematologic malignancy· 13Multiple myeloma· 11Leukemia (other)· 11Non-Hodgkin lymphoma· 11Myelodysplastic syndromes (MDS)· 10Diffuse large B-cell lymphoma (DLBCL)· 10Head and neck cancer· 9Pancreatic cancer· 8Fallopian tube cancer· 8Metastatic prostate cancer· 7Chronic lymphocytic leukemia (CLL)· 7Lung cancer· 6Gastric cancer· 6Bladder cancer· 6Cervical cancer· 6Mantle cell lymphoma· 6Neuroblastoma· 6Esophageal cancer· 5Follicular lymphoma· 5Metastatic breast cancer· 4Triple-negative breast cancer· 4Gastroesophageal junction cancer· 4Kidney cancer· 4Acute lymphoblastic leukemia· 4Myelofibrosis· 4Myeloproliferative neoplasm· 4Small lymphocytic lymphoma· 4HER2-positive breast cancer· 3HER2-negative breast cancer· 3Small cell lung cancer· 3Rectal cancer· 3Liver cancer· 3Biliary tract cancer· 3Chronic myelomonocytic leukemia· 3Hodgkin lymphoma· 3Burkitt lymphoma· 3Thyroid cancer· 3Sarcoma· 3Metastatic colorectal cancer· 2Colon cancer· 2Glioma· 2Brain cancer· 2Marginal zone lymphoma· 2Osteosarcoma· 2Ewing sarcoma· 2Mesothelioma· 2Neuroendocrine tumors· 2Uterine cancer· 1Glioblastoma· 1Brain metastases· 1Rhabdomyosarcoma· 1Pediatric cancer· 1